TORONTO: Cancer could no longer be the dreaded disease that it today is as a group of Israeli scientists say they have found the cure for cancer. “We believe we will offer in a year’s time a complete cure for cancer,” said Dan Aridor, chairman of the board of AEBi, the firm developing the new treatment.
AEBi which stands for Accelerated Evolution Biotechnologies Ltd promises to offer a cure that will be effective from day one with minimal side effects as compared to the harrowing weeks suffered by those undergoing chemotherapy today. Aridor while speaking to the Jerusalem Post also promises that the treatment being developed by AEBi will be “at much lower cost than most other treatments on the market,” adding that AEBi’s “solution will be both generic and personal.” Read: Cervical Cancer Early Symptoms Can Now Be Detected With New Test Considered ‘Better’ Than Pap Smear And HPV Test
The treatment being touted by AEBi uses peptides, a chain of amino acids, to target and kill cancer cells. The treatment is being called MuTaTo as it uses a combination of several cancer-targeting peptides for each cancer cell while it is combined with a strong peptide toxin that would kill cancer cells specifically. AEBi explains that, “By using at least three targeting peptides on the same structure with a strong toxin, we made sure that the treatment will not be affected by mutations; cancer cells can mutate in such a way that targeted receptors are dropped by the cancer.”
“Instead of attacking receptors one at a time, we attack receptors three at a time – not even cancer can mutate three receptors at the same time.”
The company, however, has only tested the treatment in mice so far. Which means it could be years before the treatment reaches the markets across the world. The treatment has been tried on lung cancer cells but Aridor says it works on other types of cancer cells as well.